In obesity, a micro-RNA causes metabolic problems

September 20, 2012
University of Illinois molecular and integrative physiology professor Jongsook Kim Kemper and her colleagues were able to reverse some of the metabolic problems associated with obesity in mice by targeting a micro-RNA. Credit: L. Brian Stauffer

Scientists have identified a key molecular player in a chain of events in the body that can lead to fatty liver disease, Type II diabetes and other metabolic abnormalities associated with obesity. By blocking this molecule, the researchers were able to reverse some of the pathology it caused in obese mice.

Their findings appear in the Proceedings of the National Academy of Sciences.

MiR-34a (pronounced MEER-34a), a micro-RNA, occurs at higher than normal levels in the livers of obese animals and in human patients with . In the new study, researchers discovered that miR-34a gums up production of a protein receptor, called beta-Klotho, needed for metabolic signaling in the liver. This hinders normal , glycogen and and other metabolic activities.

In response to signals from the small intestine, beta-Klotho contributes to normal liver function after a meal, said University of Illinois molecular and integrative physiology professor Jongsook Kim Kemper, who led the study. But in obesity, levels of miR-34a surge much higher than normal, resulting in abnormally low levels of beta-Klotho.

"The downstream effect is more glucose in the blood, more fat in the liver," she said.

The effects are dramatic. Slices of from obese mice are laden with fat, whereas normal mice have minimal amounts of fat in their livers.

The researchers used a complementary strand of RNA (called antisense RNA) to neutralize miR-34a in obese mice. This therapeutic approach improved "metabolic outcomes, including decreased liver fat and improved glucose level in the blood," Kemper said.

Explore further: Study shows soy protein alleviates symptoms of fatty liver disease

More information: "Aberrantly Elevated miR-34a in Obesity Attenuates Hepatic Responses to FGF19 by Targeting a Membrane Co-Receptor β-Klotho," Proceedings of the National Academy of Sciences, 2012. www.pnas.org/content/early/2012/09/12/1205951109.abstract

Related Stories

Recommended for you

Yo-yo dieting might cause extra weight gain

December 5, 2016

Repeated dieting may lead to weight gain because the brain interprets the diets as short famines and urges the person to store more fat for future shortages, new research by the universities of Exeter and Bristol suggests.

New target receptor discovered in the fight against obesity

November 25, 2016

The team of scientists from King's College London and Imperial College London tested a high-fat diet, containing a fermentable carbohydrate, and a control diet on mice and looked at the effect on food intake of those with ...

Does where you live affect what you weigh?

November 21, 2016

Adult obesity rates in the United States have reached epidemic proportions, with one in four people considered obese. Yet, obesity rates vary considerably across states and counties.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.